Familial Melanoma:

Around 2-5% of all melanoma is familial, meaning the increased risk is caused by DNA changes inherited in the family. DNA changes account for over 33% of familial cases. Genetic testing can help find the cause for melanoma in the family and inform risk management. However genetic testing for melanoma is not routinely ordered due to lack of dermatologists’ comfort with genetic testing, and long wait-lists to specialist genetic services. Mainstreaming melanoma genetic testing into dermatology can help improve access to genetic testing.

About the study:

This study aims to support the mainstreaming of genetic testing for melanoma into dermatology settings by:

• Educating dermatologists to provide genetic testing for familial melanoma 

• Developing a new model of care for familial melanoma, with a genetic counsellor embedded in the Dermatology Department at The Princess Alexander Hospital, Brisbane

• Evaluating the impact of the mainstreaming model of care on patient clinical, psychological and behavioural outcomes

• Evaluating the cost-effectiveness of the mainstreaming model of care

• Determining if provider type (genetic counsellor or upskilled dermatology clinician) impacts patient outcomes.

Contact us: igmgenomics@uq.edu.au